MedPath

The effect of oxytocin on prosocial behavior in social anxiety disorder

Conditions
social anxiety disorder
social phobia
10002861
Registration Number
NL-OMON37767
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
126
Inclusion Criteria

Fulfill the criteria of Social Anxiety Disorder or any other Anxiety Disorder
Age between 18 and 60 years
IQ above 80
Able to read and write in Dutch
Free of medication, except hormonal contraceptives
Absence of major medical, endocrine and neurological condition

Exclusion Criteria

Women: pregnancy or breastfeeding
Acute psychotic complaints, risk for suicide or automutulation
Dependent on alcohol or drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Videoraters will rate the amount of two social bonding behaviors, reciprocal<br /><br>self-disclosure and mimicry, and the likeability of the participants at several<br /><br>time-points during a 15-minutes social interaction. Participant rate their<br /><br>level of subjective social anxiety at several time-points during this social<br /><br>interaction. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Furthermore, it is examined whether SAD patients are less liked at first sight<br /><br>compared to a clinical and healthy control group. Last, the impact of SAD and<br /><br>possible oxytocin effects on economic decision-making are assessed by two short<br /><br>computerized tasks.</p><br>
© Copyright 2025. All Rights Reserved by MedPath